Ultrasensitive blood test predicts head and neck cancer relapse months earlier

Дата публикации: 10-06-2026 18:00:03

A new study by investigators from Mass General Brigham Cancer Institute has found that an ultrasensitive blood test called HPV-DeepSeek could help identify which people with HPV-associated head and neck cancer still had cancer cells in their bodies after surgery and may benefit the most from additional treatments. The results are published in Science Translational Medicine.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Blood test finds hidden pancreatic cancer after treatment	5	8	30-06-2026
2	New brush test detects oral cancer in one hour	7	8	06-07-2026
3	Novel biomarker research offers new hope in the fight against colorectal cancer	7	8	06-07-2026
4	Blood test may help identify which colorectal cancer patients most likely to benefit from chemotherapy after surgery	0	5	06-07-2026
5	Natera’s Steve Chapman Wants to See Cancer Coming	0	6.98	05-08-2026
6	‘Liquid biopsy’ tech contributes to successful clinical trial for detecting breast cancer recurrence	0	6.61	29-07-2020
7	Researchers expand plasmonic liquid biopsy platform to early-stage colorectal cancer	5	7	09-07-2026
8	A single blood test could spot multiple cancers early, saving lives	0	9.73	16-02-2026
9	Breakthrough for patients with pancreatic cancer as doctors develop new blood test that can pick up 'residue cells' of the 'silent' disease that killed Alan Rickman	8	7	30-06-2026
10	Genomic newborn screening could identify some children at risk for early cancers	0	8.39	12-08-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 5. Информативность: 7. Источник: medicalxpress.com.